Astal Lab

{
  "main_header": {
    "sid": 157295,
    "name": "Astal Lab",
    "stock_name": "Astal Lab",
    "full_name": "Astal Laboratories Ltd",
    "name_url": "stocks-analysis/astal-lab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "78.93",
    "chg": -0.18,
    "chgp": "-0.23%",
    "dir": -1,
    "prev_price": "79.11",
    "mcapval": "331.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 512600,
    "symbol": "",
    "ind_name": "Trading & Distributors",
    "ind_code": 49,
    "indexname": "",
    "isin": "INE307N01014",
    "curr_date": "Feb 06",
    "curr_time": "",
    "bse_nse_vol": "15.21 k",
    "exc_status": "Active",
    "traded_date": "Feb 06, 2026",
    "traded_date_str": "2026 02 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/astal-lab-157295-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Astal Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/astal-laboratories-ltd-is-rated-strong-sell-3811172",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AstalLaboratori_mojoScore_3811172.png",
        "date": "2026-01-30 10:10:03",
        "description": "Astal Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 21 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 30 January 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Astal Laboratories Declines 5.59%: Key Technical and Financial Developments This Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astal-laboratories-declines-559-key-technical-and-financial-developments-this-week-3804281",
        "imagepath": "",
        "date": "2026-01-25 15:01:15",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Jan 19:</strong> Death Cross formation signalling potential bearish trend</p>\n                    <p><strong>Jan 19:</strong> Upgrade to Hold rating by MarketsMOJO on improved fundamentals</p>\n                    <p><strong>Jan 23:</strong> Week closes at Rs.81.03 (-5.59%) amid broader market weakness</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.85.83</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.81.03</div><div class=\"stat-change negative\">-5.59%</div></div>\n                 ..."
      },
      {
        "title": "Why is Astal Laboratories Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-astal-laboratories-ltd-fallingrising-3802661",
        "imagepath": "",
        "date": "2026-01-24 00:43:04",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Astal Laboratories closed at ₹82.99, down by 0.07% or ₹0.06 as of 08:22 PM on 23 January. This slight dip continues a four-day losing streak during which the stock has declined by 3.81%. Over the past week, the stock has underperformed the benchmark Sensex, falling 3.31% compared to the Sensex’s 2.43% decline. The one-month performance is similarly weak, with Astal Laboratories down 7.50% against the Sensex’s 4.66% fall. Year-to-date, the stock has lost 4.44%, marginally worse than the Sensex’s 4.32% drop. Over the longer term, however, the stock has delivered impressive returns, rising 179.90% over three years, significantly outperforming the Sensex’s 33.80% gain in the same period.</p>\n<p><strong>Technical Indicators and Trading Acti..."
      },
      {
        "title": "Astal Laboratories Ltd Forms Death Cross Signalling Potential Bearish Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astal-laboratories-ltd-forms-death-cross-signalling-potential-bearish-trend-3794813",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AstalLaboratori_dealthcross_3794813.png",
        "date": "2026-01-19 18:00:15",
        "description": "Astal Laboratories Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development often signals a shift towards a bearish trend and suggests a deterioration in the stock’s medium to long-term momentum, raising concerns among investors about potential weakness ahead."
      },
      {
        "title": "Astal Laboratories Ltd Upgraded to Hold on Improved Technicals and Strong Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/astal-laboratories-ltd-upgraded-to-hold-on-improved-technicals-and-strong-financials-3793777",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AstalLaboratori_mojoScore_3793777.png",
        "date": "2026-01-19 08:03:18",
        "description": "Astal Laboratories Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical indicators, valuation metrics, financial trends, and overall quality. This upgrade, effective from 16 January 2026, comes amid a strong market performance and robust quarterly results, signalling a more favourable outlook for the trading and distributors sector player."
      },
      {
        "title": "Astal Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/astal-laboratories-ltd-is-rated-sell-3789752",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AstalLaboratori_mojoScore_3789752.png",
        "date": "2026-01-12 10:10:21",
        "description": "Astal Laboratories Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 29 December 2025, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 12 January 2026, providing investors with the latest perspective on the company’s position."
      },
      {
        "title": "Astal Laboratories Downgraded to Sell Amid Mixed Financials and Technical Weakness",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/astal-laboratories-downgraded-to-sell-amid-mixed-financials-and-technical-weakness-3774173",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AstalLaboratori_mojoScore_3774173.png",
        "date": "2025-12-30 08:09:57",
        "description": "Astal Laboratories Ltd has seen its investment rating downgraded from Hold to Sell, driven primarily by a deterioration in technical indicators despite robust financial performance and attractive valuation metrics. The latest assessment by MarketsMOJO reflects a nuanced view of the company’s quality, valuation, financial trend, and technical outlook as of 29 Dec 2025."
      },
      {
        "title": "Astal Laboratories Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/astal-laboratories-ltd-is-rated-hold-3769677",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AstalLaboratori_mojoScore_3769677.png",
        "date": "2025-12-25 15:12:53",
        "description": "Astal Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 23 December 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 25 December 2025, providing investors with the most recent insights into its performance and outlook."
      },
      {
        "title": "Astal Lab’s Market Evaluation Revised Amidst Microcap Challenges",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/astal-lab-downgraded-to-sell-by-marketsmojo-amid-declining-mojo-score-3749798",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AstalLab_mojoScore_3749798.png",
        "date": "2025-12-06 10:10:33",
        "description": "Astal Lab, a microcap player in the Trading & Distributors sector, has experienced a revision in its market evaluation reflecting recent shifts in its fundamental and technical outlook. This adjustment comes amid a backdrop of subdued stock performance and evolving financial indicators."
      }
    ],
    "total": 118,
    "sid": "157295",
    "stock_news_url": "https://www.marketsmojo.com/news/astal-laboratories-157295"
  },
  "announcements": [
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "24-Jan-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Aceso Research Labs LLP",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "24-Jan-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Aceso Research Labs LLP",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011",
      "datetime": "23-Jan-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sesha Sai Nikhil Chintalapati",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Astal Laboratories Ltd is Rated Strong Sell

2026-01-30 10:10:03

Astal Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 21 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 30 January 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Astal Laboratories Declines 5.59%: Key Technical and Financial Developments This Week

2026-01-25 15:01:15

Key Events This Week

Jan 19: Death Cross formation signalling potential bearish trend

Jan 19: Upgrade to Hold rating by MarketsMOJO on improved fundamentals

Jan 23: Week closes at Rs.81.03 (-5.59%) amid broader market weakness

Week Open

Rs.85.83

Week Close

Rs.81.03

-5.59%

...

Read full news article

Why is Astal Laboratories Ltd falling/rising?

2026-01-24 00:43:04

Recent Price Movement and Market Context

Astal Laboratories closed at ₹82.99, down by 0.07% or ₹0.06 as of 08:22 PM on 23 January. This slight dip continues a four-day losing streak during which the stock has declined by 3.81%. Over the past week, the stock has underperformed the benchmark Sensex, falling 3.31% compared to the Sensex’s 2.43% decline. The one-month performance is similarly weak, with Astal Laboratories down 7.50% against the Sensex’s 4.66% fall. Year-to-date, the stock has lost 4.44%, marginally worse than the Sensex’s 4.32% drop. Over the longer term, however, the stock has delivered impressive returns, rising 179.90% over three years, significantly outperforming the Sensex’s 33.80% gain in the same period.

Technical Indicators and Trading Acti...

Read full news article

Astal Laboratories Ltd Forms Death Cross Signalling Potential Bearish Trend

2026-01-19 18:00:15

Astal Laboratories Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development often signals a shift towards a bearish trend and suggests a deterioration in the stock’s medium to long-term momentum, raising concerns among investors about potential weakness ahead.

Read full news article

Astal Laboratories Ltd Upgraded to Hold on Improved Technicals and Strong Financials

2026-01-19 08:03:18

Astal Laboratories Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical indicators, valuation metrics, financial trends, and overall quality. This upgrade, effective from 16 January 2026, comes amid a strong market performance and robust quarterly results, signalling a more favourable outlook for the trading and distributors sector player.

Read full news article

Astal Laboratories Ltd is Rated Sell

2026-01-12 10:10:21

Astal Laboratories Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 29 December 2025, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 12 January 2026, providing investors with the latest perspective on the company’s position.

Read full news article

Astal Laboratories Downgraded to Sell Amid Mixed Financials and Technical Weakness

2025-12-30 08:09:57

Astal Laboratories Ltd has seen its investment rating downgraded from Hold to Sell, driven primarily by a deterioration in technical indicators despite robust financial performance and attractive valuation metrics. The latest assessment by MarketsMOJO reflects a nuanced view of the company’s quality, valuation, financial trend, and technical outlook as of 29 Dec 2025.

Read full news article

Astal Laboratories Ltd is Rated Hold

2025-12-25 15:12:53

Astal Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 23 December 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 25 December 2025, providing investors with the most recent insights into its performance and outlook.

Read full news article

Astal Lab’s Market Evaluation Revised Amidst Microcap Challenges

2025-12-06 10:10:33

Astal Lab, a microcap player in the Trading & Distributors sector, has experienced a revision in its market evaluation reflecting recent shifts in its fundamental and technical outlook. This adjustment comes amid a backdrop of subdued stock performance and evolving financial indicators.

Read full news article

View All News